Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial

Grant

Date/time Interval

  • November 1, 2015 - October 31, 2016

    • Awarded By

    Total Award Amount

  • 223000.00

    • Direct Costs

  • 202727.00

    • Sponsor Award Id

  • CTALEARN012

    • Contributor

  • David Geldmacher   Principal Investigator  
  • Erik Roberson   Investigator  
  • Khurram Bashir   Investigator  
  • Marissa Natelson Love   Investigator  
  • Roberta May   Investigator